NAD recommends B+L make changes to advertorial claims
NEW YORK — Earlier this week the National Advertising Division recommended that Bausch + Lomb modify or discontinue certain claims made in an advertorial context that refer to Alcon Laboratories’ Opti-Free RepleniSH contact lens solution.
The advertorial, challenged by Alcon, alerted eye care practitioners to an increase in reports of infiltrative keratitis, a condition that can affect the vision and comfort of contact lens wearers. Titled “Infiltrative Keratitis and Gram-Negative Bacterial Resistance to PQ-Aldox Lens Care Products,” the advertorial suggested “contact lens associated infiltrative keratitis has been reported at higher rates in particular with polyquaternium (PQ)-Aldox (myristamidopropyl dimethylamine) based multi-purpose solutions.”
In this case, NAD determined that the challenged advertorial conveyed the messages that consumers who wear silicone hydrogel lenses and use Opti-Free RepleniSH are substantially more likely to experience, or are at a greater risk for, keratitis than other contact lens solutions; and that eye care practitioners should switch their patients to the advertiser’s Biotrue solution which has been shown to reduce their patients’ risk for keratitis.
NAD determined that the advertiser’s evidence did not support any of these messages. NAD recommended that B+L modify its advertorial.
B+L, in its advertiser’s statement, said that while the company respectfully disagrees with NAD’s findings concerning the net impressions of the advertorial, it “appreciates NAD’s recommendations on how to avoid any future confusion about the intended message. Bausch + Lomb will seek ways in which to incorporate this helpful guidance in any future advertising or promotional communications about this emerging field of study.”
No comments found
Homeostasis Labs’ Diabetic Direct named ‘Best New Product’ at recent ECRM
GREENWICH, Conn. — Homeostasis Labs was named "Best New Product" by retail buyers attending the ECRM Home Health Care conference last month for a new sugar-free line of dietary supplements formulated to boost health for people with diabetes.
“We are honored that our [Diabetic Direct] line of supplements for people with diabetes has been recognized as a top new product and has been so quickly embraced by the diabetic community,” stated Kenneth Corroon, president and CEO of Homeostasis Labs. “We believe that consumers with diabetes will find this line of supplements beneficial to their overall health as well as very convenient and easy to use on a daily basis.”
The line is currently made up of four supplements, including Calcium Boost, Immunity Boost, Energy Boost and Magnesium Boost.
Each Diabetic Direct supplement comes in an individual serving sized packet with 20 to a box. The Diabetic Direct supplement line from Homeostasis Labs is available now for $9.99.
A portion of the sales of products in the Diabetic Direct line will be donated to the American Diabetes Association, the company stated.
Are you a nurse practitioner or physician’s assistant? Join our Facebook group to get all the latest news dedicated to delivering healthcare services to patients in retail pharmacy clinics.
Most excellent Research & Development; A Job Well Done and a much needed product for my patients and self...tks again...
Cirrus Healthcare Products launches new line of licensed EarPlanes featuring Disney’s ‘Planes’
COLD SPRING HARBOR, N.Y. — Cirrus Healthcare Products on Thursday announced that the company will be launching its latest licensed version of EarPlanes for Kids in conjunction with the new Disney "Planes" movie releasing on Aug. 9.
EarPlanes, which comes in two sizes fitting either a child or an adult, are designed to be worn for air travel to reduce and prevent uncomfortable ear pressure during flight — including the clogging, popping, pain or even the temporary hearing loss that can result.
The new Disney Planes licensed and printed product will help reduce the non-compliance issue with children’s earplugs, and will be available at major drug, mass market and airport retailers for an average retail price of $8 starting in June.
Like this story? Find us on Facebook for more insight, analysis and the latest in drug store news. Join the conversation.
No comments found